Haoxi Health Technology Ltd
3 hedge funds and large institutions have $62.3K invested in Haoxi Health Technology Ltd in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
202% more capital invested
Capital invested by funds: $20.6K → $62.3K (+$41.7K)
200% more funds holding
Funds holding: 1 → 3 (+2)
0.16% more ownership
Funds ownership: 0% → 0.16% (+0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$2.13M |
| 2 |
VF
Virtu Financial
New York
|
+$649K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$592K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$468 |
HAO Hedge Fund Activity: Q2 2026 in Review
3 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q2 2026, worth a combined $62.3K — up 202% from $20.6K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new HAO positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Marex Group, opening a new position worth an estimated $2.13M. The largest seller was UBS Group, cutting an estimated $468.
- 3 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q2 2026, up from 1 in Q1 2026.
- Funds reported $62.3K of Haoxi Health Technology Ltd stock for Q2 2026, up 202% quarter-over-quarter.
- 2 funds opened new Haoxi Health Technology Ltd positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest Haoxi Health Technology Ltd buyer in Q2 2026 was Marex Group, an estimated $2.13M added.
- The largest Haoxi Health Technology Ltd seller in Q2 2026 was UBS Group, an estimated $468 sold.
Based on aggregated 13F filings for Q2 2026.